HLA-C and cancer: Supporting this concept, studies using a similar bispecific approach (CD28xEGFR), showed no independent stimulation of the immune system in the absence of TCR engagement with the MHC of cancer cells, as demonstrated in both cynomolgus monkeys and genetically engineered triple-humanized mice (57).